Su, Y., Feng, Y., Wu, H., Huang, Y., Tung, C., Wu, P., . . . Wu, C. (2018). Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression. Sci Rep.
Chicago Style CitationSu, Yu-Chu, Yin-Hsun Feng, Hung-Tsung Wu, Yao-Shen Huang, Chao-Ling Tung, Pensee Wu, Chih-Jen Chang, Ai-Li Shiau, i Chao-Liang Wu. "Elovl6 Is a Negative Clinical Predictor for Liver Cancer and Knockdown of Elovl6 Reduces Murine Liver Cancer Progression." Sci Rep 2018.
Cita MLASu, Yu-Chu, et al. "Elovl6 Is a Negative Clinical Predictor for Liver Cancer and Knockdown of Elovl6 Reduces Murine Liver Cancer Progression." Sci Rep 2018.
Atenció: Aquestes cites poden no estar 100% correctes.